Changing Metal Powder Characteristics for Elimination of the Heavy Metals Toxicity and Diseases in Disruption of Extracellular Matrix (ECM) Proteins Adjustment in Cancer Metastases Induced by Osteosarcoma, Chondrosarcoma, Carcinoid, Carcinoma, Ewing’s Sarcoma, Fibrosarcoma and Secondary Hematopoietic Solid or Soft Tissue Tumors

Abstract
Modern science is based on interaction among disciplines. Pharmaceutical and medicinal chemistry has transformed the materials of everyday life, but this is merely a quick look of the future of pharmaceutical and medicinal materials such as intelligent molecules that behave as a sensor, self–reproducing pharmaceutical and medicinal compounds, molecules that work (Nano-Engineering) and even molecules that think may transform our world in ways not yet imagined [1-6]. These developments are the result of cooperation among pharmaceutical chemists, physicists, engineers, material scientists, computer experts, pharmacists, medicinal chemists and many others. The most dramatic developments at the beginning of the twenty–first century are new methods in chemistry, pharmacology, pharmaceutical sciences and medicine from collaborations among pharmaceutical and medicinal chemists and biologists. In this opinion, changing metal powder characteristics for elimination of the heavy metals toxicity and diseases in disruption of Extracellular Matrix (ECM) proteins adjustment in cancer metastases induced by osteosarcoma, chondrosarcoma, carcinoid, carcinoma, Ewing’s sarcoma, fibrosarcoma and secondary hematopoietic solid or soft tissue tumors have been investigated.